Femasys Ownership
FEMY Stock | USD 1.11 0.05 4.72% |
Femasys |
Femasys Stock Ownership Analysis
The book value of the company was currently reported as 0.85. The company recorded a loss per share of 0.81. Femasys had not issued any dividends in recent years. Femasys Inc., a biomedical company, focuses on womens healthcare market in the United States. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia. Femasys operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. To learn more about Femasys call the company at 770 500 3910 or check out https://www.femasys.com.Besides selling stocks to institutional investors, Femasys also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Femasys' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Femasys' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Femasys Quarterly Liabilities And Stockholders Equity |
|
About 8.0% of Femasys are currently held by insiders. Unlike Femasys' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Femasys' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Femasys' insider trades
Femasys Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Femasys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Femasys backward and forwards among themselves. Femasys' institutional investor refers to the entity that pools money to purchase Femasys' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Nordwand Advisors Llc | 2024-09-30 | 5 K | Nelson, Van Denburg & Campbell Wealth Management Group, Llc | 2024-09-30 | 4.3 K | Tower Research Capital Llc | 2024-09-30 | 4 K | Bank Of America Corp | 2024-09-30 | 3.2 K | Harbour Investments, Inc. | 2024-09-30 | 1000 | Cm Management, Llc | 2024-09-30 | 425 K | Geode Capital Management, Llc | 2024-09-30 | 206.5 K | Royal Bank Of Canada | 2024-09-30 | 52.9 K | Xtx Topco Ltd | 2024-09-30 | 32.5 K | Tri Locum Partners Lp | 2024-09-30 | 30.6 K | Sontag Advisory Llc | 2024-09-30 | 28.1 K |
Femasys Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Femasys insiders, such as employees or executives, is commonly permitted as long as it does not rely on Femasys' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Femasys insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Femasys Outstanding Bonds
Femasys issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Femasys uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Femasys bonds can be classified according to their maturity, which is the date when Femasys has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin |
Additional Tools for Femasys Stock Analysis
When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.